ea0073oc9.4 | Oral Communications 9: Endocrine-Related Cancer | ECE2021
López-Cánovas Juan Luis
, Hermán-Sánchez Natalia
, Moreno-Montilla María T
, del Rio-Moreno Mercedes
, Sánchez-Frias Marina E.
, Amado Víctor
, Ciria Rubén
, Briceño Javier
, de la Mata Manuel
, Castaño Justo P.
, Rodriguez-Perálvarez Manuel
, Luque Raul M
, Gahete Ortiz Manuel
Endocrine-metabolic alterations such as obesity and metabolic syndrome are closely linked to the development of chronic liver diseases, from metabolic-associated fatty liver (MAFLD) to non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). An emerging hallmark of endocrine-metabolic and hepatic diseases is the appearance or altered expression of pathological splicing variants (SVs). In fact, the components of the cellular machinery involved in the splicing pr...